Information Provided By:
Fly News Breaks for November 9, 2015
LXRX
Nov 9, 2015 | 15:14 EDT
Wedbush analyst Liana Moussatos raised Lexicon's price target to $26 to reflect peak sales for T2DM for sotagliflozin. Moussatos rates Lexicon an Outperform.
News For LXRX From the Last 2 Days
There are no results for your query LXRX